Recent advances in radiation therapy of head and neck cancer
โ Scribed by Seagren, Stephen L.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1982
- Weight
- 567 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0148-6403
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The major advances in radiation oncology in this century was the development of megavoltage radiation in the 1950s, which greatly expanded the clinical utility of ionizing radiation in the treatment of many forms of cancer, including cancers of the head and neck. The combination of radiation and surgery for improved control of local and regional cancers followed. The use of interstitial implant therapy is growing rapidly because of new materials and techniques, thus expanding the radioโtherapeutic options available to the oncologist. Investigations into several other therapeutic modalities currently are being carried out. These modalities include the use of particle radiation, oxygenโmimicking drugs, and hyperthermia, primarily in efforts to overcome the need for the oxygen effect in tumors. New uses of chemotherapy in combination with radiation also are being explored. Details of these activities within the field of radiation oncology are discussed.
๐ SIMILAR VOLUMES
## Abstract Due to the close spatial relationship of head and neck and skull base tumors to numerous normal anatomical structures, conventional photon radiation therapy can be associated with significant acute and longโterm treatmentโrelated toxicities. Superior dose localization properties of prot
## Abstract Three patients with locally advanced head and neck squamous cell cancer received concomitant radiation therapy (XRT) and cisโdiamminedichloroplatinum (CDDP). The dose of 6,000 rads was to be administered in two 3,000โrad courses separated by 3 weeks. The CDDP, 30 mg/m^2^, was to be give
## Abstract ## Objectives: This is a pilot study designed to identify gene expression profiles able to stratify head and neck squamous cell carcinoma (HNSCC) tumors that may or may not respond to chemoradiation or radiation therapy. ## Study Design: We prospectively evaluated 14 HNSCC specimens,